期刊文献+

氟伐他汀对糖尿病大鼠肾脏核因子κB表达的影响 被引量:1

Effects of Fluvastatin on the Expression Nuclear Factor-kappa B in the Kidney of Diabetic Rats
下载PDF
导出
摘要 目的:通过糖尿病大鼠模型,观察氟伐他汀对大鼠肾脏的保护作用。方法:SD大鼠随机分3组,即正常对照组、糖尿病组(DM组)、氟伐他汀治疗组。以链脲佐菌素(STZ)制备糖尿病大鼠模型,大鼠饲养4周分别取出肾脏检测NF-κB的表达。检测各组大鼠血糖、血脂2、4 h尿蛋白定量等指标。采用免疫组织化学技术检测各组肾小球中NF-κB的表达。结果:糖尿病大鼠肾小球NF-κB表达较正常肾组织增高,治疗4周后,小剂量氟伐他汀对血糖、血脂水平无影响,但可明显降低糖尿病肾病大鼠肾小球中NF-κB的表达,并减少蛋白尿。结论:氟伐他汀对糖尿病大鼠肾脏保护作用可能通过非依赖降脂的保护作用,其机制至少部分与下调肾小球中NF-κB表达有关。 Objective: To study the protective effects of fluvastatin on the kidneys of diabetic rats. Methods: The models of diabetic rats were induced by streptozotocin. SD rats were randomly divided into three groups as control group, diabetic group and fluvastatin treated group. After four weeks, blood glucose, serum cholesterol and urinary protein were measured respectively. The expression of NF-κB in the glomerulus was determined by immunohistochemical staining. Results: Fluvastatin did not influence blood glucose and serum cholesterol, but significantly inhibited the expression of NF-κB and lowered urinary protein excretion. Conclusion: Fluvastatin could protect the kidneys of diabetic rats probably through inhibiting the overexpression of NF-κB,independent of cholesterol-lowering effects.
出处 《武汉大学学报(医学版)》 CAS 2007年第5期595-597,I0002,共4页 Medical Journal of Wuhan University
关键词 氟伐他汀 核因子ΚB 糖尿病肾病 Fluvastatin Nuclear Factor-kappa B Diabetic Nephropathy
  • 相关文献

参考文献7

  • 1Hansen HP,Tauber LE,Jensen BR,et al.Effects of dietary protein in restriction on progression in patients with diabetic nephropathy[J].Kidney Int,2002,62:220-228.
  • 2Karin M,Ben Neriah Y.Phosphorylation meets ubiquitination:the control of NF-κB activity[J].Ann Rev Immunol,2000,18:621-663.
  • 3Katoh M,Kurosawa Y,Tanaka K,et al.Fluvastatin inhibits O2 and ICAM-1 levels inaratmodel with aortic remodeling induced by pressure overload[J].Am J Physiol Heart Circ Physiol,2001,281:655-660.
  • 4Morrissery J,Klahr S.Transcription factor NF-κB regulation of renal fibrosis during ureteral obstruction[J].Seminars in Nephrology,1998,18:603-610.
  • 5Wada T,Furuichi K,Sakai N,et al.Up regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of humandiabetic nephropathy[J].Kidney Int,2000,58:1 492-1 497.
  • 6Chen HC,Guh JY,Shin SJ,et al.Pravastatin suppress super oxide and fibronect in production of glomerular mesangial cells induced by oxidized LDL and high glucose[J].Atherosclerosis,2002:160:141-146.
  • 7Usui H,Shikata K,Matsuda M,et al.HMG CoA reductase inhibitor a meliorates diabetic nephropathy by its pleiotropic effects in rats[J].Nephrol Dial Transplant,2003,18:265-272.

同被引文献14

  • 1International Diabetes Federation. Diabetes Atlas Exec- utive Summary[M]. Third edition. International Dia- betes Federation Publication, 2006 : 111-115.
  • 2The ADVANCE Collaborative Group. Intensive blood glucose control and vascularoutcomes in patients with type 2 diabetes[J]. N Engl J Med, 2008,358:2 560- 2 572.
  • 3Mezzano S, Aros C, Droguett A, et al. NF-kappa B activation and overexpression of regulated genes in hu- man diabetic nephropathy [J]. Nephrol Dial Trans- plant, 2004,19(10):2 505-2 512.
  • 4Ha H,Yu MR,Choi YJ,et al. Role of high glucose-in- duced nuclear factor-kappaB activation in monocyte che- moattractant protein-1 expression by mesangial cells [J]. J AmSoc Nephrol,2002,13(4):894-902.
  • 5Iino K,Yoshinari M,Iwase M,et al. The role of oxida- tive stress induced NF-B in the development of diabetic nephropathy[J]. IDialaetologia, 1999, 1 031 (Suppl) : A273-A273.
  • 6Pepper C, Hewamana S, grennan P, et al. NF-KappaB as a prognostic marker and therapeutictarget in chronic lymphocytic leukemia[J]. Future Oncol, 2009,5 ( 7 ) : 1 027-1 037.
  • 7Papa S, Bubici C, Zazzeroni F, et al. Mechanisms of liver disease:Cross-talk between the NF-Kappa B and J NK pathways[J]. Biol Chem, 2009,390 (10) : 965-976.
  • 8Chariot A. The NF-Kappa B-independent function of IKK subunits in immunity and eancer[J]. Trends Cell biol, 2009,19(8) :404-413.
  • 9Khachigian LM, Collins T, Fries JW. N-acetyl cyste ine blocks mesangial VCAM-1 and NF-kappa B expres sion in vivo [J ]. Am Pathol, 1997, 151(5): 1 225 1 229.
  • 10Mohamed MR, Mcfadden G. NF-KappaB inhibitors: strateyies from poxviruses[J]. Cell Cycle,2009,8(19) : 3 125-3 132.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部